Randox Toxicology Ltd.
Philip Robinson has extensive experience in sales and business development within the diagnostics industry, currently serving as Vice President of Sales at both Randox Toxicology Ltd. and Randox Food Diagnostics since September 2011 and August 2019, respectively. Prior roles include Business Development Manager for Europe and the Middle East, as well as Business Development Executive for the Middle East at Randox Toxicology Ltd. Philip Robinson holds a BA (Hons) in Business Management from Edinburgh Napier University, where studies were completed from 2007 to 2011, and attended Bangor Grammar School from 1999 to 2006.
This person is not in any teams
This person is not in any offices
Randox Toxicology Ltd.
Delivering innovative solutions for fast and accurate drug detection, Randox Toxicology is a primary manufacturer of Biochip Array Technology, ELISA, reagents, automated systems and quality control material for clinical and forensic toxicology. With the world’s largest toxicology test menu detecting over 500 drugs and metabolites, Randox Toxicology are continually first to market with novel drug tests including synthetics cannabinoids, kratom, DOx Series and bath salts. Patented Biochip Array Technology, designed to work across multiple matrices, boasts cutting-edge multiplex testing capabilities facilitating simultaneous drug detection from a single sample. Significant re-investment in Research & Development has allowed Randox Toxicology to transform the landscape of drugs of abuse testing, offering the most advanced screening technology on the market.